Long-term open-label continuation study of the safety and efficacy of belimumab for up to 7 years in patients with systemic lupus erythematosus from Japan and South Korea.

Details

Language :

English

ISSN :

20565933

Volume :

7

Database :

Complementary Index

Journal :

RMD Open

Publication Type :

Academic Journal

Accession number :

151375838

Full Text :

https://doi.org/10.1136/rmdopen-2021-001629